134 related articles for article (PubMed ID: 4305439)
1. Veterinary vaccines.
LaSalle B
Natl Cancer Inst Monogr; 1968 Dec; 29():515-22. PubMed ID: 4305439
[No Abstract] [Full Text] [Related]
2. Experience with an established cell line for veterinary vaccine production.
Brown AL
Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440
[No Abstract] [Full Text] [Related]
3. Studies of an established canine kidney-cell line.
Brown AL; Davis EV; Beckenhauer WH
Cornell Vet; 1968 Oct; 48(4):593-613. PubMed ID: 4301040
[No Abstract] [Full Text] [Related]
4. Characteristics of primary cultures and diploid cells--technology of production.
Holper JC
Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
[No Abstract] [Full Text] [Related]
5. [Standardization of the titration of lyophilized turkey herpes virus vaccines against Marek's disease].
Ingwersen P; Monreal G; Beyer G
Berl Munch Tierarztl Wochenschr; 1974 Oct; 87(20):389-92. PubMed ID: 4422314
[No Abstract] [Full Text] [Related]
6. Tissue and medium antigens in vaccines.
Coriell LL
Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
[No Abstract] [Full Text] [Related]
7. Non-parenteral vaccines for veterinary use in the United Kingdom.
Frerichs GN
Dev Biol Stand; 1976; 33():29-32. PubMed ID: 986328
[TBL] [Abstract][Full Text] [Related]
8. Documentation and classification of oncogenic viruses.
Huebner RJ
Natl Cancer Inst Monogr; 1968 Dec; 29():319-26. PubMed ID: 4305430
[No Abstract] [Full Text] [Related]
9. Vaccination by the non-parenteral route of virus disease in the veterinary field.
Menassé I
Dev Biol Stand; 1976; 33():33-40. PubMed ID: 182589
[TBL] [Abstract][Full Text] [Related]
10. Cytopathology in viral diseases.
Cheville NF
Monogr Virol; 1975; 10():1-224. PubMed ID: 172783
[No Abstract] [Full Text] [Related]
11. Large-scale cultivation of animal cells in roller bottles for production of decigram amounts of pure foot-and-mouth disease virus.
Bachrach HL
Natl Cancer Inst Monogr; 1968 Dec; 29():73-9. PubMed ID: 4305442
[No Abstract] [Full Text] [Related]
12. Viral flora of tissue sources--simian and human.
Kalter SS; Heberling RL
Natl Cancer Inst Monogr; 1968 Dec; 29():149-60. PubMed ID: 4305427
[No Abstract] [Full Text] [Related]
13. Immunization of experimental animals with vaccines produced in known oncogenic cell lines.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():503-9. PubMed ID: 5720804
[No Abstract] [Full Text] [Related]
14. Production of veterinary vaccines in mammalian cell cultures.
Sellers RF
Lab Pract; 1970 Jan; 19(1):42-4. PubMed ID: 5416447
[No Abstract] [Full Text] [Related]
15. Experience with vaccines--summary.
Koprowski H; Jackson GG
Natl Cancer Inst Monogr; 1968 Dec; 29():565-6. PubMed ID: 5720809
[No Abstract] [Full Text] [Related]
16. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
17. Evidence for oncogenic properties of heteroploidy cell lines.
Sanford KK
Natl Cancer Inst Monogr; 1968 Dec; 29():283-7. PubMed ID: 5720798
[No Abstract] [Full Text] [Related]
18. Immunity to bivalent tissue culture origin equine encephalomyelitis vaccine.
Gutekunst DE
J Am Vet Med Assoc; 1969 Jul; 155(2):368-74. PubMed ID: 5816119
[No Abstract] [Full Text] [Related]
19. Vaccines produced in diploid cell lines--discussion.
Perkins FT
Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
[No Abstract] [Full Text] [Related]
20. Canary pox vaccination with live embryo-attenuated virus.
Hitchner SB
Avian Dis; 1981; 25(4):874-81. PubMed ID: 6279074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]